A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis....1 The impacts of medication errors also represent a
burden for health systems, with the annual cost associated with medication errors estimated at USD 42 billion
worldwideharm
more
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...macies and primary healthcare facilities) and in
hospital settings, as well as for pharmacists working as clinical biologists in medical
analysis laboratories, for example, as clinical biologists, and offer a set of references that
may be consulted for more informationstor
more
Nursing Care Protocol for adult patients with COVID-19 without respiratory complications
COVID-19, General Epidemiological Surveillance Guidelines (Version 6)
Protocol for strategic implementation of mental health in COVID-19 emergencies ( Version 2)
Guidelines for diagnosis, acute care and post-COVID-19 follow-up for children and adolescents
Vaccinator's Manual. MODERNA Vaccine
Guidelines for the care of children and adolescents diagnosed with COVID - 19.
Community Health Volunteers
Connecting global priorities: biodiversity and human health: a state of knowledge review
Evaluation of the effectiveness of vaccines against COVID-19
INTERIM GUIDANCE 17 MARCH 2021
Hypertension and COVID-19: Scientific report - 17 June 2021
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021